Challenges and Innovations in COVID-19 Vaccine Development

This chapter explores the initial challenges faced during the COVID-19 vaccine development in the UK, including the uncertainty surrounding vaccine efficacy. The speakers highlight the rapid decision-making and innovative approaches that led to expedited trials, emphasizing collaboration within the biopharmaceutical industry. It also discusses the establishment of a national citizen registry to facilitate participant recruitment and the personal experiences of trial participants, showcasing the impact of these efforts on public health.